• Home
  • Education
  • Searchable Multimedia Library

Webinars


This page contains exclusive content for the member of the following sections: TTS, CTS. Log in to view.

Bridging the Gap in Translational Regenerative Medicine: From Genomic Inclusion and iPSC Innovation to Clinical Testing

0.0 - Bridging the Gap in Translational Regenerative Medicine: From Genomic Inclusion and iPSC Innovation to Clinical Testing

Presenter: Multiple, Presenters, ,
Authors: Janine Scholefield, Hongkui Deng

Overview

Dr. Scholefield will discuss the importance of embedding African genetic diversity into global research pipelines. Africa encompasses more genetic variation than the rest of the world yet this rich diversity is critically under-represented in medical research and treatments, not the least of which is due to dearth of cellular tools and medicines generated on the African continent. Consequently, medicines developed in the Global North often lead to sub-optimal treatment outcome, where nearly 10% of South African hospitalizations are caused by adverse drug reactions. With the alignment of mutually beneficial collaborations, North – South partnerships can ensure that access to Africa’s vast genetic heritage is positively embedded in global R&D pipelines.

Dr. Deng will discuss his journey from chemically-induced stem cell-derived islets (CiPSC) line generation to clinical testing of CiPSC-derived islets through transplantation for Regenerative Medicine. In 2022, his team demonstrated that small molecules can effectively reprogram human somatic cells to pluripotent stem cells. Their chemical approach provides a new platform for the generation and application of human pluripotent stem cells in biomedicine. Most recently, chemically-induced stem cell-derived islets (CiPSC-islets) were transplanted underneath the abdominal anterior rectus sheath of a patient, resulting in rapid reversal of diabetes. The results from the first patient suggest feasibility of this treatment modality and warrant its further exploration.

Learning Objectives

  • Highlight the critical need for incorporating African genetic diversity into global biomedical research and its impact on treatment outcomes.
  • Explore strategies for fostering equitable North–South collaborations in genomic science and drug development.
  • Understand the development and clinical potential of chemically-induced pluripotent stem cells (CiPSCs) for regenerative medicine.
  • Examine the translational journey from in vitro CiPSC-based platforms to successful clinical application through islet transplantation.

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717 x216
sections@tts.org

Address

Cell Transplant and Regenerative Medicine Society
c/o The Transplantation Society
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada